Completed PHASE1 INTERVENTIONAL NCT00871234

Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study

Effects of Etravirine (INTELENCETM) on Endothelial Function in HIV-uninfected Adults: A Pilot Study

Sponsor: Indiana University

Conditions Endothelial Function HIV Infections Inflammation Insulin Resistance Lipids

Interventions Etravirine

Updated 5 times since 2017 Last updated: Jan 5, 2011 Started: Apr 30, 2009 Primary completion: Mar 31, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Endothelial Function and HIV Infections, this trial is completed. The trial is conducted by Indiana University and has accumulated 5 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indiana University
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indianapolis, United States